{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2020, Part 3
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about eight drugs recently approved by the FDA.Learning Objectives
After completing this continuing education activity you will be able to:
- Describe indications for eight newly approved drugs.
- Identify nursing implications for these new drugs.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$17.95
Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: N1020B
Published: Oct 2020
Expires: 12/6/2024
Sources:
Nursing2024
Required Passing Score: 14/18 (77%)
Topics:
Drug Update
,
Medications